The prevalence of obstructive sleep apnea (OSA) in patients with severe asthma and the association between severity of OSA and asthma control Source: Virtual Congress 2020 – Phenotyping sleep-disordered breathing and its impact on various diseases Year: 2020
The influence of obesity and overweight on hypercapnic and hypoxic respiratory responses in obstructive sleep apnoea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 183s Year: 2003
Auto-CPAP for treatment of OSAS in severe obese patients Source: Eur Respir J 2005; 26: Suppl. 49, 723s Year: 2005
Differences in levels of systemic inflammation markers between obese subjects with or without obstructive sleep apnea Source: Annual Congress 2010 - Biomarkers for oxidative stress, inflammation and cardiovascular function in sleep apnoea Year: 2010
Association of risk of obstructive sleep apnea and asthma control among adult Filipino patients with asthma Source: Virtual Congress 2021 – The different faces of sleep disturbances in respiratory diseases and beyond Year: 2021
Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Chronic hypercapnia in morbidly obese patients with obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Determinants of hypercapnia in obese obstructive sleep apnea (OSA) patients Source: Eur Respir J 2004; 24: Suppl. 48, 447s Year: 2004
Could neutrophilic airway inflammation in obese people be more due to obstructive sleep apnoea syndrome than to asthma? Source: Eur Respir J 2012; 39: 1547-1549 Year: 2012
A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011
Endothelin-1 levels, respiratory drive and hypercapnic response in obese patients with or without obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Lung disease and mountain sickness: the importance of ventilatory control Year: 2010
The symptom prevalence of obstructive sleep apnea syndrome in patients with asthma and COPD Source: Eur Respir J 2006; 28: Suppl. 50, 198s Year: 2006
Chronic hypercapnia in patients with OSAS with and without COPD Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005
Cardiovascular and metabolic effects of CPAP in obese obstructive sleep apnoea patients Source: Eur Respir J 2008; 31: 223-225 Year: 2008
Prevalence of day-time hypercapnia or hypoxia in patients with OSAS and normal lung function Source: Eur Respir J 2002; 20: Suppl. 38, 493s Year: 2002
Prevalence, predictors and impact of nocturnal hypoxemia in non-apnoeic patients with COPD Source: International Congress 2015 – Clinical assessment in asthma and COPD Year: 2015
The prevalence of unrecognized obstructive sleep apnea syndrome among patients with nocturnal symptoms and poorly controlled asthma Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities Year: 2017
Prevalence of obstructive sleep apnea in patients with difficult-to-treat asthma Source: Annual Congress 2011 - Asthma: risk factors and comorbidities Year: 2011
OSA phenotypes in asthma and COPD Source: International Congress 2018 – From continuous positive airway pressure (CPAP) and adherence to CPAP to asthma-COPD overlap syndrome (ACOS) Year: 2018
Low prevalence of obstructive sleep apnoea in paediatric severe therapy resistant asthma Source: International Congress 2019 – Asthma education: lifestyle and adolescence Year: 2019